HavenRx

HavenRx™ is a pioneering healthcare startup that aims to revolutionize the pharmaceutical industry with its innovative approach. The company's slogan, "Deliver prescription medications & devices with 50-state Rx infrastructure & seamless insurance billing with HavenRx™," encapsulates its mission to streamline the delivery and payment processes associated with prescription medications. Founded in 2018 and based in the United States, HavenRx™ has garnered significant attention in the industry. HealthHaven, the flagship product of HavenRx™, offers a 50-state pharmacy solution with API-driven ordering and white-labelled fulfillment. This unique approach enables organizations to establish an onsite or online pharmacy with a single contract. The company's technology-driven model leverages wholesale pricing to reduce medication costs for members/employees by over 20%, leading to diminished administration efforts and improved health outcomes. Moreover, HealthHaven's API-based delivery and adherence infrastructure further enhances its appeal. In June 2023, HavenRx™ secured a notable $250.00K investment in its Seed Round from Blue Cross Blue Shield of Massachusetts and Zaffre Investments. This funding not only underscores the confidence of prominent investors in the company's vision but also provides HavenRx™ with the resources to drive its expansion and innovation initiatives. With its focus on disrupting the healthcare and pharmaceutical industries, HavenRx™ presents an exciting prospect for potential investors seeking to make a meaningful impact in these sectors.